FDA Enforcement Class II Terminated

220/240V AC, Advanced Perfusion System Platform (APS) The Terumo¿ Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of blood for arterial perfusion, regional perfusion, and cardiopulmonary bypass procedures, when used by a qualified medical professional who is experienced in the operation of this or similar equipment.

Recall: Z-0436-2013 · Reported December 5, 2012

Enforcement

Recall Number
Z-0436-2013
Event ID
63543
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Terumo Cardiovascular Systems Corporation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
December 5, 2012
Initiation Date
November 14, 2012
Classification Date
November 27, 2012
Termination Date
August 30, 2013
Address
6200 Jackson Road, N/A, Ann Arbor, MI, 48103-9586, United States

Description

220/240V AC, Advanced Perfusion System Platform (APS) The Terumo¿ Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extracorporeal circulation of blood for arterial perfusion, regional perfusion, and cardiopulmonary bypass procedures, when used by a qualified medical professional who is experienced in the operation of this or similar equipment.

Reason

Terumo Cardiovascular System (TCVS) has received reports of a situation where users experienced a total loss of functionality for some System 1 units. The reports indicate that the units went blank and shut down with no sign of power and battery backup did not initiate. The result is all pumps stop, with no safety system functionality, and the battery would not be activated. The user would be

Code Info

Catalog number: 801764 and all serial numbers

Distribution

Worldwide Distribution--USA (nationwide) including the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WA, WI, and WV.

Quantity

1647 units total